Slingshot members are tracking this event:

Immunomedics (IMMU) Expects Updated Phase 2 Results for IMMU-130 in Metastatic Colorectal Cancer in 1H 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 18, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Updated Results, Phase 2 Data, Immu-130, Metastatic Colorectal Cancer, 1h 2016